Day Five – 20 June 2025 - CEST Time Zone
- Rina Sant - Associate Director, Regulatory Affairs Post-Market Management, Abbott
Current regulatory landscape and expectations for post market surveillance and vigilance in Europe
Have there been any notable changes?
Are there any areas under review to watch out for?
Which sections of PMS guidance consistently trip people up?
Solutions to overcome
With UK PMS regulations having come into force in 2024, what are our first experiences?
Do expectations align with Europe?
Can manufacturers streamline PMS activities for both regions?
Are there common pain points which need addressing?
- Mika Reinikainen - Managing Director at Abnovo Ltd and Chairman, UK Responsible Person Association
Please contact: Kristen Schott – kristen.schott@informa.com If you are interested in participating as a speaker, panelist, moderator or hosting a webinar
Role of PMS in the Benefit-Risk Framework
Regulatory Expectations for PMS Data Collection
Risk Identification and Management via PMS
Impact of Post-Market Data on Benefit-Risk Decisions
Cross-Functional Collaboration for Effective Benefit-Risk and PMS
- Ella Helgeman - Senior Regulatory Director, Radiometer
How do you decide what Continuous PMCF activity is appropriate for each class of device?
What systems and tools are key for creating?
How do you implement?
Set up a decision tree to help guide your decisions in the PMCF World
Can you Create a Proactive and Maneuverable PMS/PMCF System to be globally supportive
- Rina Sant - Associate Director, Regulatory Affairs Post-Market Management, Abbott
- Rina Sant - Associate Director, Regulatory Affairs Post-Market Management, Abbott
Understanding Real-World Evidence
Integration of RWE in Post-Market Surveillance
Regulatory Landscape
Case studies
Challenges and Opportunities
Future directions
- Dilşat Pınar Pergjetani - Chief Quality & Regulatory Affairs Officer, Human Care HC AB
- Outline of a Practical Approach to Integrating MDCG 2022-21 Requirements: Effective integration into the Quality Management System to meet regulatory demands.
- Utilization of the PSUR Structure for Streamlined Input Templates: Developing department-specific templates to ensure consistent, compliant data collection across teams.
- Breaking Down Silos Through Direct Involvement: Enhancing cross-departmental collaboration by focusing on a unified PSUR project goal, rather than on isolated task completion.
- Fostering a Collaborative Environment: Bridging perspectives across departments to promote a cohesive approach to quality management.
- Kristin Ulbrich - Senior Post-Market Surveillance Specialist, HOYA Surgical Optics
- Josep Pané - Head of Device and Digital Vigilance and Safety, UCB
Please contact: Kristen Schott – kristen.schott@informa.com If you are interested in participating as a speaker, panelist, moderator or hosting a webinar
What are the current regulatory expectations for adverse event reporting?
How are notified bodies assessing this?
Industry experiences of reporting adverse events
Can current processes be more standardised?
Streamlining stakeholder interactions
Can AI be used to alleviate workload?
- Miloš Stojković - Safety Process Director, Roche